Diabetes Type 2

 
In Adults with T2D, Low-energy Diets with Meal Replacement Most Effective for Weight Loss, Remission
November 22, 2021

Weight loss and disease remission in T2D may differ between patients regardless of type of diet regimen chosen, say authors of a new analysis.

Canagliflozin Improved HF Symptoms, QOL Regardless of Diabetes Status in Fully Remote Clinical Trial
November 16, 2021

AHA 2021. Heart failure patients, across ejection fraction and diabetes status, reported improved QOL as early as 3 months in CHIEF-HF trial.

Finerenone Slows CKD Progression Across Disease Spectrum, According to New Analysis
November 08, 2021

Finerenone was associated with a 20% lower risk of end-stage kidney disease among patients with T2D and CKD, according to authors of the FIDELITY analysis.

Cardiovascular Risk Found Greatest in Prediabetes A1c Range
October 28, 2021

For individuals with A1c of 6.4-6.5%, just below the threshold for diabetes, risk of MACE was higher than for any other subgroup with A1c values ranging from 5.8-6.8%.

COVID-19 Lockdown Had Significant, Yet Varying, Impact on Glycemic Control
October 04, 2021

EASD 2021: First analysis of its kind found COVID-19-induced lockdown was associated with improved glycemic control among patients with T1D, but not T2D.

SUSTAIN-10 Post-hoc Analysis Suggests Additive Benefits for GLP-1 RA-SGLT-2i Combination
September 29, 2021

This post-hoc analysis showed increased reductions in A1c, weight, and BP in T2D patients prescribed GLP-1 receptor agonists who were already taking an SGLT-2 inhibitor.

Reverse-dipping BP, Heart Rate Variability Linked to Increased All-cause Mortality in Diabetes
September 29, 2021

A pattern of nocturnal reverse-dipping blood pressure in persons with type 1 or 2 diabetes put them at more than twice the risk of all-cause mortality, according to new research.

Sustained Weight Loss May Reverse CV Risk Factors Linked to Obesity, Study Shows
September 28, 2021

EASD 2021: For persons who have had obesity, returning to a healthy weight may reduce risk for hypertension and dyslipidemia, and modestly for diabetes.

Women with T2D Less Likely to Receive Guideline-recommended Cardiovascular Care vs Men
September 28, 2021

EASD 2021: Women with type 2 diabetes were less likely to meet targets for CV risk management vs men but at lower risk for future CV events, a new study found.

Prevalence of Type 1 and Type 2 Diabetes “Surging” among US Youth, Shows New Study
September 08, 2021

From 2001 to 2017, the estimated prevalence of youth-onset T1D and T2D increased approximately 45% and 95%, respectively, according to a new study.